Deals

A chessboard with blocks that read MA
Biotech

Sino Biopharm buys Merck’s PD-1xVEGF bispecific partner LaNova

LaNova's PD-1xVEGF bispecific antibody was licensed to Merck in a $588 million upfront deal.
Angus Liu Jul 15, 2025 10:16am
colorful brain art model

Acumen taps JCR’s brain barrier tech for $555M Alzheimer’s deal

Jul 15, 2025 8:01am
Realistic white price tags collection Special offer or shopping discount label

China biotechs ‘reshaping’ US biopharma: Jefferies report

Jul 14, 2025 2:30pm
MA strategy deal block push come together form

Research non-profit acquires embattled Essa in Xoma-backed deal

Jul 14, 2025 9:30am
Return To Sender stamp on an envelope

Relmada dumps depression asset after slew of phase 3 failures

Jul 11, 2025 12:12pm
Glowing puzzle piece fitting into puzzle

Eolas regains opioid use disorder drug abandoned by AstraZeneca

Jul 10, 2025 9:33am